DeMuro C, Gnanasakthy A, Price M, Winnette R, Desphande A. Development of a daily diary to assess signs and symptoms of genital herpes. Poster presented at the 2017 ISPOR 22nd Annual International Meeting; May 22, 2017. Boston, MA. [abstract] Value Health. 2017 May; 20(5):A80.
Twiss J, McKenna SP, Bloch M, Bonney M. Patient and clinician perceived benefit of early consumption of famciclovir for the treatment of herpes outbreaks. Poster presented at the 2011 ISPOR 14th Annual European Congress; November 2011. Madrid, Spain. [abstract] Value Health. 2011 Nov; 14(7):A266. doi: 10.1016/j.jval.2011.08.193
Doward LC, McKenna SP, Meads DM, Kahler K, Frech F. The development of the Herpes Symptom Checklist (HSC) and the Herpes Outbreak Impact Questionnaire (HOIQ). Value Health. 2009 Jan 1;12(1):139-45.
Doward LC, McKenna SP, Meads DM. Development of the herpes outbreak impact questionnaire (HOIQ). Poster presented at the 2003 ISPOR 6th Annual European Congress; November 2003. Barcelona, Spain. [abstract] Value Health. 2003 Nov; 6(6):760-1.
Doward LC, McKenna SP, Meads DM, Ratcliffe J, Langley PC. Assessing disease-specific utility in recurrent genital herpes (RGH). Value Health. 2003 Jan 1;6(3):270-1.
Doward LC, Ratcliffe J, McKenna SP, Meads DM, Langley PC. A comparison of conjoint analysis and time trade off elicited utilities for quality of life states associated with the treatment of genital herpes. Poster presented at the 2002 ISPOR 5th Annual European Congress; November 2002. [abstract] Value Health. 2002 Nov 3; 5(6):574. doi: 10.1016/S1098-3015(10)61510-0
Doward LC, McKenna SP, Meads DM, Ratcliffe J, Whalley D, Langley PC. Investigation into the feasibility of deriving relative and absolute utility from the recurrent genital herpes quality of life questionnaire (RGHQOL). Poster presented at the 2002 ISPOR 5th Annual European Congress; November 2002. Rotterdam, The Netherlands. [abstract] Value Health. 2002 Nov; 5(6):573-4.